Vyome (HIND)
Develops topical therapies for inflammatory conditions and cancer-wound symptoms.
$2.23
Pre-market+0.01 (+0.45%)
At close$2.22(+2.30%)
Something off on this page? Send us feedback.
Next report
Nov 13, 2026
in 71 days
EPS estimate
−$0.21
Revenue estimate
$24.1K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
May '25Aug '25Nov '25Mar '26May '26May '26Aug '26Nov '26
Reported$18.98−$2.25−$3.12−$0.47−$0.15−$0.15−$0.10Pending
Estimate——−$0.11−$0.47−$0.15−$0.15−$0.19−$0.21
Surprise——−2,736.4%0.0%0.0%0.0%+47.4%—
RevenueReportedEstimate
May '25Aug '25Nov '25Mar '26May '26May '26Aug '26Nov '26
Reported$1.1M$1.2M$34.6K$36.6K$31.6K$31.6K$27.0KPending
Estimate———$36.6K$31.6K$31.6K$27.0K$24.1K
Surprise———0.0%0.0%0.0%0.0%—
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.21 | — | — |
| Aug 2026 | −$0.19 | −$0.10 | +47.4% |
| May 2026 | −$0.15 | −$0.15 | 0.0% |
| May 2026 | −$0.15 | −$0.15 | 0.0% |
| Mar 2026 | −$0.47 | −$0.47 | 0.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Nov 2025 | |||
| Aug 2025 | |||
| May 2025 | |||
| Apr 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Apr 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Jul 2020 | |||
| Jun 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Jul 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Oct 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | −$0.21 | — | — | $24.1K | — | — | — |
| Aug 12, 2026 | −$0.19 | −$0.10 | +47.4% | $27.0K | $27.0K | 0.0% | −1.3% |
| May 19, 2026 | −$0.15 | −$0.15 | 0.0% | $31.6K | $31.6K | 0.0% | +5.0% |
| May 12, 2026 | −$0.15 | −$0.15 | 0.0% | $31.6K | $31.6K | 0.0% | −3.0% |
| Mar 26, 2026 | −$0.47 | −$0.47 | 0.0% | $36.6K | $36.6K | 0.0% | −3.2% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||||||
| Nov 14, 2025 | |||||||
| Aug 14, 2025 | |||||||
| May 20, 2025 | |||||||
| Apr 4, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Aug 14, 2024 | |||||||
| May 15, 2024 | |||||||
| Apr 1, 2024 | |||||||
| Feb 23, 2024 | |||||||
| Nov 8, 2023 | |||||||
| Aug 7, 2023 | |||||||
| May 15, 2023 | |||||||
| Mar 29, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 19, 2022 | |||||||
| May 23, 2022 | |||||||
| Mar 28, 2022 | |||||||
| Nov 11, 2021 | |||||||
| Aug 16, 2021 | |||||||
| May 12, 2021 | |||||||
| Mar 12, 2021 | |||||||
| Nov 6, 2020 | |||||||
| Jul 30, 2020 | |||||||
| Jun 19, 2020 | |||||||
| Feb 27, 2020 | |||||||
| Nov 8, 2019 | |||||||
| Jul 24, 2019 | |||||||
| May 10, 2019 | |||||||
| Feb 22, 2019 | |||||||
| Nov 2, 2018 | |||||||
| Aug 2, 2018 | |||||||
| May 10, 2018 | |||||||
| Mar 5, 2018 | |||||||
| Nov 3, 2017 | |||||||
| Aug 2, 2017 | |||||||
| May 10, 2017 | |||||||
| Feb 23, 2017 | |||||||
| Oct 5, 2016 | |||||||
| Aug 4, 2016 | |||||||
| May 5, 2016 | |||||||
| Feb 17, 2016 | |||||||